BDNF and Cognitive impairment: Our results align with those of previous reports, demonstrating that chronic scopolamine administration significantly induced gut microbiota dysbiosis, disrupted intestinal barrier function, increased systemic inflammation, and decreased serum and brain BDNF levels, thereby validating the utility of this animal model for investigating probiotics and milk-based interventions for cognitive deficits.